Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use

计划入组 324 人 · 首次发布于 2016 年 6 月 9 日

Pediatric Ease of Use ELLIPTA Items

计划入组 28 人 · 首次发布于 2017 年 10 月 20 日

Arnuity® Ellipta® Drug Use Investigation

计划入组 336 人 · 首次发布于 2017 年 6 月 12 日

Nemiralisib

C₂₆H₂₈N₆O

GSK-1614235/GSK-2330672

GSK-3844766A

Gsk Consumer Healthcare Sarl

Denmark

GlaxoSmithKline

United Kingdom

GLAXOSMITHKLINE TRADING SERVICES LIMITED

Spain

3P Innovation Launches Next-Generation DPI Filling Technology, Promising Faster Production of Inhalable Therapeutics

GSK's Relvar Ellipta Demonstrates Superior Asthma Control in Landmark Real-World Study

Transpire Bio Achieves First Human Dosing Milestone for Novel CNS Inhalation Therapy